You cannot log in without being assigned a valid TSI role.
The MSP, a Division of TSI, Next Generation Impactor (NGI) is a high-performance cascade impactor with seven stages.
It is and has been the industry standard pharmaceutical cascade impactor for the last 20 years, with 1800+ units in use and adopted into the USP guidelines. It was designed and developed by and for the OINDP Industry, and is the most efficient and accurate way to do standard in vitro APSD testing. There are many automated and semi-automated add-ons as well as other accessories designed to further improve efficiency.
The NGI+ uses the same industry proven design and substitutes materials to enable a wider range of applications, chemicals, and drugs. The NGI+ provides more corrosion protection, enhanced chemical and biological resistance, and a longer equipment life expectancy for your inhaler testing process. Whether you are testing nebulizers, using biologics, or looking for more robust or even perhaps automated cleaning solutions, the NGI+ expands your options.
(Next Generation Impactor)
(Next Generation Impactor Plus)
Mensuration and calibration are imperative in pharmaceutical testing, and is recommended by the FDA (Food and Drug Administration), USP (United States Pharmacopeia), and GMP (Good Manufacturing Practices).
MSP provides calibration and mensuration services, as well as calibration contracts and extended warranties as part of our QualityGuard™ program.
Learn More and Request Service Today
MSP is proud to present the new NGI+! Visit our webpage to learn how the NGI+ can expand your options.
More MSP Pharmaceutical Test Solutions